Colestipol Hydrochloride

盐酸考来替泊

Report date: 2022/02/10 11:23:50
NME

Base Information

Drug NameColestipol Hydrochloride
Drug Alias Name考来替泼ColestipolumColestid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid binding protein modulators
TargetsBile acid binding protein
Therapy Area/IndicationsHyperlipidemiasProtoporphyria, Erythropoietic
Global Approved IndicationsHyperlipidemias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1977/04/04
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmacia & Upjohn
Active IndicationsHyperlipidemias
Inactive IndicationsProtoporphyria, Erythropoietic

Other Information

ATC CodeC10AC02